107 related articles for article (PubMed ID: 33745745)
1. Race disparities in genetic alterations within Wilms tumor specimens.
Apple AN; Neuzil KE; Phelps HM; Li B; Lovvorn Iii HN
J Pediatr Surg; 2021 Jun; 56(6):1135-1141. PubMed ID: 33745745
[TBL] [Abstract][Full Text] [Related]
2. Wilms tumor, pleuropulmonary blastoma, and DICER1: case report and literature review.
Abbo O; Pinnagoda K; Brouchet L; Leobon B; Savagner F; Oliver I; Galinier P; Castex MP; Pasquet M
World J Surg Oncol; 2018 Aug; 16(1):164. PubMed ID: 30097050
[TBL] [Abstract][Full Text] [Related]
3. Biallelic DICER1 mutations occur in Wilms tumours.
Wu MK; Sabbaghian N; Xu B; Addidou-Kalucki S; Bernard C; Zou D; Reeve AE; Eccles MR; Cole C; Choong CS; Charles A; Tan TY; Iglesias DM; Goodyer PR; Foulkes WD
J Pathol; 2013 Jun; 230(2):154-64. PubMed ID: 23620094
[TBL] [Abstract][Full Text] [Related]
4. Race disparities in Wilms tumor incidence and biology.
Axt J; Murphy AJ; Seeley EH; Martin CA; Taylor C; Pierce J; Caprioli RM; Whiteside M; Lovvorn HN
J Surg Res; 2011 Sep; 170(1):112-9. PubMed ID: 21529835
[TBL] [Abstract][Full Text] [Related]
5. Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour.
Palculict TB; Ruteshouser EC; Fan Y; Wang W; Strong L; Huff V
J Med Genet; 2016 Jun; 53(6):385-8. PubMed ID: 26566882
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrences.
Spreafico F; Ciceri S; Gamba B; Torri F; Terenziani M; Collini P; Macciardi F; Radice P; Perotti D
Oncotarget; 2016 Feb; 7(8):8908-15. PubMed ID: 26802027
[TBL] [Abstract][Full Text] [Related]
7. Germline DICER1 mutations and familial cystic nephroma.
Bahubeshi A; Bal N; Rio Frio T; Hamel N; Pouchet C; Yilmaz A; Bouron-Dal Soglio D; Williams GM; Tischkowitz M; Priest JR; Foulkes WD
J Med Genet; 2010 Dec; 47(12):863-6. PubMed ID: 21036787
[TBL] [Abstract][Full Text] [Related]
8. Race disparities in peptide profiles of North American and Kenyan Wilms tumor specimens.
Libes JM; Seeley EH; Li M; Axt JR; Pierce J; Correa H; Newton M; Hansen E; Judd A; McDonald H; Caprioli RM; Naranjo A; Huff V; O'Neill JA; Lovvorn HN;
J Am Coll Surg; 2014 Apr; 218(4):707-20. PubMed ID: 24655859
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors.
Wegert J; Ishaque N; Vardapour R; Geörg C; Gu Z; Bieg M; Ziegler B; Bausenwein S; Nourkami N; Ludwig N; Keller A; Grimm C; Kneitz S; Williams RD; Chagtai T; Pritchard-Jones K; van Sluis P; Volckmann R; Koster J; Versteeg R; Acha T; O'Sullivan MJ; Bode PK; Niggli F; Tytgat GA; van Tinteren H; van den Heuvel-Eibrink MM; Meese E; Vokuhl C; Leuschner I; Graf N; Eils R; Pfister SM; Kool M; Gessler M
Cancer Cell; 2015 Feb; 27(2):298-311. PubMed ID: 25670083
[TBL] [Abstract][Full Text] [Related]
10. Genetic and chromosomal alterations in Kenyan Wilms Tumor.
Lovvorn HN; Pierce J; Libes J; Li B; Wei Q; Correa H; Gouffon J; Clark PE; Axt JR; Hansen E; Newton M; O'Neill JA;
Genes Chromosomes Cancer; 2015 Nov; 54(11):702-15. PubMed ID: 26274016
[TBL] [Abstract][Full Text] [Related]
11. Loss or oncogenic mutation of DROSHA impairs kidney development and function, but is not sufficient for Wilms tumor formation.
Kruber P; Angay O; Winkler A; Bösl MR; Kneitz S; Heinze KG; Gessler M
Int J Cancer; 2019 Mar; 144(6):1391-1400. PubMed ID: 30367465
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of a Long Noncoding RNA-Associated Competing Endogenous RNA Network in Wilms Tumor.
Zhang F; Zeng L; Cai Q; Xu Z; Liu R; Zhong H; Mukiibi R; Deng L; Tang X; Xin H
Cancer Control; 2020; 27(2):1073274820936991. PubMed ID: 32597194
[TBL] [Abstract][Full Text] [Related]
13. The DGCR8 E518K mutation found in Wilms tumors leads to a partial miRNA processing defect that alters gene expression patterns and biological processes.
Vardapour R; Kehl T; Kneitz S; Ludwig N; Meese E; Lenhof HP; Gessler M
Carcinogenesis; 2022 Mar; 43(2):82-93. PubMed ID: 34919667
[TBL] [Abstract][Full Text] [Related]
14. Extending the phenotypes associated with DICER1 mutations.
Foulkes WD; Bahubeshi A; Hamel N; Pasini B; Asioli S; Baynam G; Choong CS; Charles A; Frieder RP; Dishop MK; Graf N; Ekim M; Bouron-Dal Soglio D; Arseneau J; Young RH; Sabbaghian N; Srivastava A; Tischkowitz MD; Priest JR
Hum Mutat; 2011 Dec; 32(12):1381-4. PubMed ID: 21882293
[TBL] [Abstract][Full Text] [Related]
15. A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor.
Gadd S; Huff V; Walz AL; Ooms AHAG; Armstrong AE; Gerhard DS; Smith MA; Auvil JMG; Meerzaman D; Chen QR; Hsu CH; Yan C; Nguyen C; Hu Y; Hermida LC; Davidsen T; Gesuwan P; Ma Y; Zong Z; Mungall AJ; Moore RA; Marra MA; Dome JS; Mullighan CG; Ma J; Wheeler DA; Hampton OA; Ross N; Gastier-Foster JM; Arold ST; Perlman EJ
Nat Genet; 2017 Oct; 49(10):1487-1494. PubMed ID: 28825729
[TBL] [Abstract][Full Text] [Related]
16. Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors.
Walz AL; Ooms A; Gadd S; Gerhard DS; Smith MA; Guidry Auvil JM; Meerzaman D; Chen QR; Hsu CH; Yan C; Nguyen C; Hu Y; Bowlby R; Brooks D; Ma Y; Mungall AJ; Moore RA; Schein J; Marra MA; Huff V; Dome JS; Chi YY; Mullighan CG; Ma J; Wheeler DA; Hampton OA; Jafari N; Ross N; Gastier-Foster JM; Perlman EJ
Cancer Cell; 2015 Feb; 27(2):286-97. PubMed ID: 25670082
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
[TBL] [Abstract][Full Text] [Related]
18. Absence of the TRIP13 c.1060C>T Mutation in Wilms Tumor Patients From Pakistan.
Rashid MU; Naeemi H; Qazi AQ; Muhammad N; Ahmad M; Akhtar N; Rahman N
J Pediatr Hematol Oncol; 2020 Apr; 42(3):e128-e131. PubMed ID: 31574018
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
[TBL] [Abstract][Full Text] [Related]
20. [Treatment strategy for children with Wilms tumor].
Fukuzawa M
Nihon Geka Gakkai Zasshi; 2005 Jul; 106(7):422-6. PubMed ID: 16045185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
